Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...

Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

More and more people are being diagnosed with pancreatic cancer. This disease is insidious, often only making itself known in ...

Genelux Corporation’s GNLX share price has dipped by 12.21%, which has investors questioning if this is right time to buy.

RNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.

Experimental therapy uses a modified virus to boost immunity and make anti-tumour treatments more effective, according to ...

NEIGHBOURS veteran Ian Smith has given an update on his health after being diagnosed with terminal cancer in December. The ...

The AACR poster presentation will provide an update on the data in AML patients most recently presented at the American ...

With the newly completed OT-101 and IL-2 Phase 1 trial, Oncotelic is poised to begin further combination trials to determine the added efficacy of OT-101, IL-2, and CKIs in solid tumors such as lung ...

Proposed NIH cuts cloud the future of cancer research in Oregon. "We are so close right now to these amazing discoveries, ...

Encouraging preclinical data supporting the use of DNase-based technology to target NETosis and address difficult to treat ...

"We are pleased to welcome Preetam to Elicio's executive team,” said Robert Connelly, Ph.D., President and Chief Executive ...